Details for New Drug Application (NDA): 088934
✉ Email this page to a colleague
NDA 088934 describes SULFINPYRAZONE, which is a drug marketed by Barr, Ivax Pharms, Par Pharm, Vangard, and Watson Labs, and is included in eight NDAs. Additional details are available on the SULFINPYRAZONE profile page.
The generic ingredient in SULFINPYRAZONE is sulfinpyrazone. There are four drug master file entries for this compound. Additional details are available on the sulfinpyrazone profile page.
The generic ingredient in SULFINPYRAZONE is sulfinpyrazone. There are four drug master file entries for this compound. Additional details are available on the sulfinpyrazone profile page.
Summary for 088934
| Tradename: | SULFINPYRAZONE |
| Applicant: | Par Pharm |
| Ingredient: | sulfinpyrazone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088934
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
| Approval Date: | Sep 6, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
